Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4‐year study

Publisher: John Wiley & Sons Inc

E-ISSN: 1469-0691|20|11|O952-O959

ISSN: 1198-743x

Source: CLINICAL MICROBIOLOGY INFECTION, Vol.20, Iss.11, 2014-11, pp. : O952-O959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract